New York, New York, United States In 1996 was created The Global Emerging Markets Group, which is appeared as Corporate Investor. The venture was found in North America in United States. The main department of described Corporate Investor is located in the New York.
The top activity for fund was in 2017. Considering the real fund results, this Corporate Investor is 63 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2016. This The Global Emerging Markets Group works on 38 percentage points more the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the The Global Emerging Markets Group, startups are often financed by Saudi Crown Holding, 32 Ventures. The meaningful sponsors for the fund in investment in the same round are Global Equity Partners Beteiligungs-Management. In the next rounds fund is usually obtained by GVA Capital.
Among the most popular portfolio startups of the fund, we may highlight WISeKey, Relief Therapeutics, Northcore Technologies. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Network Security, Online Games. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. The fund has specific favorite in a number of founders of portfolio startups.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Advenio Capital Management | Connecticut, Greenwich, United States |
| Bestseller Group | - |
| Brava Investments | New York, New York, United States |
| ClearArc Capital | Cincinnati, Ohio, United States |
| Constant Capital | Accra, Ghana, Greater Accra |
| Energia | Hiroshima, Hiroshima Prefecture, Japan |
| Epic Games | Cary, North Carolina, United States |
| Grand Prix Capital | Australia, Bondi, New South Wales |
| Innov8on | Mazowieckie, Poland, Warsaw |
| JS Capital Management | New York, New York, United States |
| Khaleeji Commercial Bank | Bahrain, Capital Governorate, Manama |
| Leerink Partners | Boston, Massachusetts, United States |
| RFW Banro Investments | - |
| ShareLink Capital | China, Shanghai |
| Skayle | Central, Central Region, Singapore |
| The Motley Fool | Alexandria, United States, Virginia |
| Weiji Investment | China, Guangdong, Shenzhen |
| Xinhua Huijin | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
KaJ Labs | 18 May 2022 | Seattle, Washington, United States | |||
Relief Therapeutics | $2M | 24 May 2016 | Zurich, Zurich, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
KaJ Labs | 18 May 2022 | Seattle, Washington, United States | |||
Relief Therapeutics | $2M | 24 May 2016 | Zurich, Zurich, Switzerland |
